Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Omalizumab (an anti-IgE antibody) in the treatment of severe atopic eczema.
PubMed
Details
Locations
Year:
2011
Type:
article
Source:
PubMed
Authors:
M E Ramírez del Pozo,
E Contreras Contreras,
J López Tiro,
J Gómez Vera
Institution:
Institute for Social Security and Services for State Workers
Language:
English
Topic:
Dermatology and Skin Diseases
Subfield:
Dermatology
Field:
Medicine
Domain:
Health Sciences
Keywords:
omalizumab,
anti-IgE,
atopic dermatitis,
severe eczema,
treatment
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W89924499
FWCI:
3.828
Cites:
Cited by:
36
Related to:
10